Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.35 USD | +1.50% | -8.78% | -87.58% |
Financials (USD)
Sales 2024 * | 39.35M | Sales 2025 * | 58.17M | Capitalization | 74.16M |
---|---|---|---|---|---|
Net income 2024 * | -120M | Net income 2025 * | -77M | EV / Sales 2024 * | -1.35 x |
Net cash position 2024 * | 127M | Net cash position 2025 * | 54.53M | EV / Sales 2025 * | 0.34 x |
P/E ratio 2024 * |
-0.68
x | P/E ratio 2025 * |
-1.3
x | Employees | 166 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.02% |
Latest transcript on Marinus Pharmaceuticals, Inc.
1 day | +1.50% | ||
1 week | -8.78% | ||
Current month | -4.26% | ||
1 month | -82.05% | ||
3 months | -86.36% | ||
6 months | -78.40% | ||
Current year | -87.58% |
Managers | Title | Age | Since |
---|---|---|---|
Scott Braunstein
CEO | Chief Executive Officer | 60 | 18-09-04 |
Steven Pfanstiel
DFI | Director of Finance/CFO | 51 | 21-04-11 |
Joseph Hulihan
CTO | Chief Tech/Sci/R&D Officer | 68 | 19-11-05 |
Members of the board | Title | Age | Since |
---|---|---|---|
Tim Mayleben
BRD | Director/Board Member | 63 | 08-11-30 |
Scott Braunstein
CEO | Chief Executive Officer | 60 | 18-09-04 |
Elan Ezickson
BRD | Director/Board Member | 60 | 19-12-11 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.96% | 11 M€ | -6.03% | - | |
0.02% | 0 M€ | 0.00% | - | |
0.02% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-13 | 1.35 | +1.50% | 922,471 |
24-05-10 | 1.33 | -3.97% | 2,058,410 |
24-05-09 | 1.385 | -3.15% | 1,221,211 |
24-05-08 | 1.43 | -8.92% | 2,402,294 |
24-05-07 | 1.57 | +6.08% | 1,304,147 |
Delayed Quote Nasdaq, May 13, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-87.58% | 74.16M | |
+29.98% | 682B | |
+30.34% | 586B | |
-3.52% | 364B | |
+18.59% | 327B | |
+4.07% | 285B | |
+16.21% | 240B | |
+9.66% | 209B | |
-6.83% | 203B | |
+7.09% | 165B |
- Stock Market
- Equities
- MRNS Stock